SGS, the world’s leading testing, inspection and certification company, announces that it has entered into definitive agreements to acquire three additional companies as part of its strategy to relaunch M&A: Gossamer Security Solutions (“Gossamer”) in the United States, as well as Analisis Quimico y Microbiologico SAS (“AQM”) and Cromanal SAS (“Cromanal”) in Colombia.
Gossamer is a world-class provider of cybersecurity evaluation, testing and consulting services for connected devices. It is a leader in the assessment of product conformance to Common Criteria, the international set of standards for IT security certification. Founded in 2012 and headquartered in Maryland, United States, Gossamer employs 30 highly specialized employees and generates high growth. The acquisition is expected to close on 31 July 2024.
AQM and Cromanal are key players in the Colombian pharmaceutical testing industry. The companies hold key accreditations and offer microbiology, physico-chemical, liquid and gas chromatography services in raw materials and finished products, as well as stability studies and validations. Founded in 1995 and 2006 respectively, AQM and Cromanal are headquartered in Bogota, Colombia and employ 140 employees in total. The acquisitions are subject to antitrust approval.
Géraldine Picaud, CEO of SGS, commented:
“We are delighted to welcome the talented teams of Gossamer, AQM and Cromanal to SGS.
“Gossamer further enhances the power of our Brightsight brand in the growing cybersecurity market and reinforces our leading position in North America.
“AQM and Cromanal strengthen our portfolio in pharmaceutical testing and provide very attractive opportunities to expand in Life Sciences.
“These acquisitions fully align with Strategy 27 to capture the powerful megatrends of our industry and rebalance our geographic footprint.”
